This advanced screening panel evaluates cumulative genetic risk for common chronic diseases by analyzing thousands of subtle DNA variations, enabling early intervention and personalized prevention.

Analyzes multiple genetic variants to estimate your inherited likelihood of developing heart disease, hypertension, or experiencing a cardiovascular event over your lifetime.
Evaluates combined genetic factors that influence metabolism, insulin sensitivity, and blood sugar regulation, indicating predisposition to Type 2 diabetes.
Assesses a broad network of genetic markers linked to brain aging, inflammation, and neurodegeneration to estimate lifetime risk for Alzheimer's disease and cognitive decline.
Examines polygenic markers across tissues to gauge inherited susceptibility to common cancers (breast, prostate, colon), beyond single-gene mutations.